Breast Cancer Female trials recruiting in Massachusetts

All Breast Cancer Female trials nationally

Cities in Massachusetts

Recruiting trials in Massachusetts

• DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
  NCT06176261 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston
• ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
  NCT07198724 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston
• Supporting Health Including Endocrine Treatment for Long Duration
  NCT07482384 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 49 Years · Sex: Female · Massachusetts: Boston
• TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
  NCT05535192 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: Female · Massachusetts: Boston